Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating Endoplasmic Reticulum Stress as a Prophylactic Approach Against Symptomatic Viral Infection

NCT04267809 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT04267809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04267809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating Endoplasmic Reticulum Stress as a Prophylactic Approach Against Symptomatic Viral Infection
Lead sponsor
Singapore General Hospital
Phase
Phase 2
Overall status
Completed
Start date
October 22, 2021
Completion date
July 31, 2023
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endoplasmic reticulum stress, viral infection, yellow fever